# Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia

> **NCT00961142** · PHASE2 · TERMINATED · sponsor: **University Hospital Tuebingen** · enrollment: 23 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Fludarabine, Thiotepa, Melphalan, Thymoglobuline (ATG)

## Key facts

- **NCT ID:** NCT00961142
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2015-12-30
- **Final completion:** 2015-12-30
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** slow recruitment
- **Last updated:** 2022-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00961142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00961142, "Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00961142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*